Press release
Why the Inflammatory Bowel Disease Treatment Market is Booming: USD 34.5 Billion Forecast by 2031
Inflammatory Bowel Disease Treatment Market
Treatment for IBD typically includes conventional therapies such as biologics and small-molecule drugs, which help manage inflammation and improve patient outcomes.
According to a report published by Allied Market Research, the global inflammatory bowel disease treatment market was valued at $21.0 billion in 2021 and is projected to reach $34.5 billion by 2031, growing at a CAGR of 5.1% from 2022 to 2031.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/4318
Market Dynamics and Growth Drivers
The growth of the IBD treatment market is driven by several factors, including:
Increasing prevalence of ulcerative colitis and Crohn's disease
Rising global awareness regarding gastrointestinal disorders
Advancements in drug development and biologics
Growing government initiatives supporting disease management
Additionally, continuous innovation in pharmaceutical research is contributing to improved treatment options and expanding market opportunities.
Impact of COVID-19
The COVID-19 pandemic had a positive impact on the IBD treatment market. Patients undergoing immunosuppressive therapies were considered more vulnerable, leading to increased government support and healthcare attention. Moreover, the pandemic encouraged pharmaceutical companies to enhance collaborations and accelerate innovation, which continues to benefit the market in the post-pandemic period.
Market Segmentation
By Type:
Ulcerative Colitis
Crohn's Disease
By Drug Class:
TNF Inhibitors
Corticosteroids
Aminosalicylates
JAK Inhibitors
Anti-integrin Therapies
IL Inhibitors
Others
By Distribution Channel:
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Regional Insights
North America dominated the market in 2021, accounting for over two-fifths of the global share, owing to advanced healthcare infrastructure and strong presence of key players. However, the Asia-Pacific region is expected to witness the fastest growth, with a projected CAGR of 6.6%, driven by increasing healthcare investments and rising patient awareness.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/4318
Key Market Players
Leading companies operating in the global IBD treatment market include:
AbbVie Inc.
Bristol Myers Squibb
Celltrion Healthcare
Eli Lilly
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Takeda Pharmaceutical Company Ltd.
UCB S.A.
Key Benefits for Stakeholders
Comprehensive analysis of market trends, dynamics, and opportunities
Insights into key drivers, restraints, and growth factors
Porter's Five Forces analysis for strategic decision-making
Detailed segmentation to identify high-growth areas
Regional and country-level revenue analysis
Competitive benchmarking of key players
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why the Inflammatory Bowel Disease Treatment Market is Booming: USD 34.5 Billion Forecast by 2031 here
News-ID: 4436015 • Views: …
More Releases from Allied Market Research (AMR)
Advanced Composites Market Competitive Analysis: Trends, Leaders and Strategic M …
The global advanced composites market is witnessing substantial growth, fueled by increasing demand for carbon fiber and S-glass fiber composites across the aerospace and defense sector, expanding industrialization in emerging economies, and growing utilization of carbon fiber composites in multiple end-use industries.
According to a recent report published by Allied Market Research titled "Advanced Composites Market by Product Type (Carbon Fiber, Glass Fiber, and Aramid Fiber), Resin Type (Thermoplastic and Thermoset),…
Polycarbonate Sheets Market: How Industry Leaders Are Defending and Expanding Sh …
The global polycarbonate sheets market is witnessing steady expansion, fueled by increasing demand from major end-use sectors such as electrical & electronics, construction, automotive, and transportation industries. Growing industrialization and rising applications of durable, lightweight materials continue to strengthen market growth worldwide.
According to a recent study by Allied Market Research, the global polycarbonate sheets market was valued at $1.5 billion in 2021 and is projected to reach $2.6 billion by…
Glycol Ethers Market 2026: A Closer Look at Competitive Strategies and Market Le …
The global glycol ethers market is witnessing steady expansion, fueled by increasing applications in paints and coatings along with strong growth across pharmaceutical, cosmetic, and personal care industries. Glycol ethers continue to gain traction due to their versatility as solvents and chemical intermediates across multiple industrial sectors.
According to a report published by Allied Market Research titled "Glycol Ethers Market by Type (E-series and P-series), Application (Solvent, Anti-icing, Hydraulic and Brake…
Hydrogen Peroxide Market Landscape: Strategic Competition Across Key Regions and …
The global hydrogen peroxide market is witnessing substantial growth, fueled by increasing consumption across the pulp and paper sector, expanding healthcare applications, and growing utilization in wastewater treatment and industrial processing. The versatile chemical compound continues to gain prominence due to its strong oxidizing and disinfecting properties, supporting its adoption across numerous industries worldwide.
According to a recent report published by Allied Market Research, titled "Hydrogen Peroxide Market by Application (Chemical…
More Releases for IBD
Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An …
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models.
New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies.
Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg
Imaging techniques play a crucial…
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period.
Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149
Key Market Highlights
• Crohn's Disease Dominates: Crohn's disease…
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…
